Endobronchial Ultrasound Biopsy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Endobronchial Ultrasound Biopsy Market is segmented by Product, Application (Cancer Diagnosis, Infection Diagnosis, Others) and Geography

Market Snapshot

endobronchial-ultrasound-biopsy-market_Market Summary
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 4.36 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Endobronchial ultrasound (EBUS) is a technique that is used by pulmonologists to sample (biopsy) and visualize the structure around the tracheobronchial tree. The EBUS and endobronchial ultrasound-guided transbronchial needle aspiration (EBUS TBNA) are techniques that are effective procedures to evaluate pulmonary nodules and diagnose lung infections and stages of lung cancer.

The endobronchial ultrasound biopsy market is estimated to grow in the near future. The rise in the geriatric population with increasing incidence of diseases that require endoscopic ultrasound procedures, large patient pool with respiratory disorders, and an increase in demand for minimally invasive procedures are the primary drivers that propel the growth of this market. However, the cost of medical devices and the lack of reimbursement policies in developing countries are likely to restrain the market.

Scope of the Report

Endobronchial ultrasound is a technique that is used for biopsy and visualization of the structure around the tracheobronchial tree.

By Product
Biopsy Forceps
Cytology Brushes
Biopsy Needles
Transbronchial Aspiration Needles
Spray Catheters
By Application
Cancer Diagnosis
Infection Diagnosis
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Cancer Diagnosis segment is expected to dominate the market

Cancer Research UK suggests that the population suffering from cancer is expected to increase in the future. If the incidence of major cancers and population growth continue to be consistent, there may be 27.5 million new cancer cases worldwide each year, by 2040. This is an increase of 61.7% from 2018 and it is expected to be higher in males, with an increase of about 67.6%, as compared to females, with an estimated increase of 55.3%. Moreover, lung cancer is the 3rd most common cancer in the UK, accounting for 13% of all new cancer cases, and is also expected to increase. As a result of high and increasing prevalence of Cancer, the demand for Endobronchial Ultrasound Biopsy procedures is expected to increase in the future

Endobronchial Ultrasound Biopsy - 1

North America is expected to dominate the market

According to the American Cancer Society’s 2019 report, an estimated 228,150 new cases of lung cancer comprising of 116,440 men and 111,710 women were estimated to have occurred in the United States (US) in 2019. Moreover, about 142,670 deaths from lung cancer (76,650 in men and 66,020 in women) were also estimated.

However, the US has a well-structured healthcare system that promotes researches and technological advancements. As a result, most global players have their presence in the US. Hence the demand for Endobronchial Ultrasound Biopsy procedures for cancer diagnosis helps the market grow.

Endobronchial Ultrasound Biopsy Market 2

Competitive Landscape

The majority of the Endobronchial Ultrasound Biopsy equipment is being manufactured by the global key players. Market leaders with more funds for research and a better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing the emergence of some small players due to the rise of awareness. This has also helped the market grow.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Geriatric Population

      2. 4.2.2 Increasing Prevalence of Respiratory Disorders

      3. 4.2.3 Increasing demand for Minimally Invasive Procedures

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Equipment

      2. 4.3.2 Lack Reimbursement Policies in Developing Countries

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product

      1. 5.1.1 Biopsy Forceps

      2. 5.1.2 Cytology Brushes

      3. 5.1.3 Biopsy Needles

      4. 5.1.4 Transbronchial Aspiration Needles

      5. 5.1.5 Spray Catheters

      6. 5.1.6 Others

    2. 5.2 By Application

      1. 5.2.1 Cancer Diagnosis

      2. 5.2.2 Infection Diagnosis

      3. 5.2.3 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 ACE Medical Devices Pvt. Ltd.

      2. 6.1.2 Boston Scientific Corporation

      3. 6.1.3 CLINODEVICE

      4. 6.1.4 CONMED Corporation

      5. 6.1.5 Cook Group Incorporated

      6. 6.1.6 ENDO-FLEX GmbH

      7. 6.1.7 Medi-Globe Corporation

      8. 6.1.8 Medtronic Plc

      9. 6.1.9 Micro-Tech Endoscopy

      10. 6.1.10 Olympus Corporation

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Endobronchial Ultrasound Biopsy Market market is studied from 2018 - 2026.

The Endobronchial Ultrasound Biopsy Market is growing at a CAGR of 4.36% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Medtronic PLC, Boston Scientific Corporation, Cook Group Incorporated, CONMED Corporation, Olympus Corporation are the major companies operating in Endobronchial Ultrasound Biopsy Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!